Audi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.50 M
as on 03-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -94.08%
(FY 2020)
- Profit -1155.53%
(FY 2020)
- Ebitda 75.45%
(FY 2020)
- Net Worth -65.77%
(FY 2020)
- Total Assets -72.41%
(FY 2020)
About Audi Pharmaceuticals
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Babu Modu, Shaik Ali, and Guttula Rao serve as directors at the Company.
- CIN/LLPIN
U74120AP2016PTC098137
- Company No.
098137
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Audi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaik Ali  | Managing Director | 06-Sep-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Babu Modu | Director | 06-Sep-2022 | Current |
| Guttula Rao | Director | 28-Oct-2022 | Current |
Financial Performance of Audi Pharmaceuticals.
Audi Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 94.08% decrease. The company also saw a substantial fall in profitability, with a 1155.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 65.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Audi Pharmaceuticals?
Unlock access to Audi Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Audi Pharmaceuticals?
Unlock and access historical data on people associated with Audi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Audi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Audi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
